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Thanks to well-established quantitative functional assays and prospective isolation methods, hematopoietic
stem cells (HSCs) are among the best understood stem cells. Nevertheless, recent studies have identified
new HSC subtypes with distinct properties within previously characterized populations, leading us to
question long-held views on the underlying basis of HSC heterogeneity.Hematopoietic Stem Cells: The Classical Quantitative
Stem Cell Model
Throughout our lives, millions of blood cells die every second and
are replaced by the right kind and number of new cells. This
amazing regenerative capacity is sustained by hematopoietic
stem cells (HSCs). These cells have the potential to differentiate
into both lymphoid (B cell, T cell, natural killer cell, and lymphoid
dendritic cell lineage) and myeloid (all other lineages) blood cells.
When they divide, they can generate at least one daughter cell
with HSC potential (i.e., self-renew) and thus maintain the stem
cell pool. Although some other multipotent hematopoietic
progenitor cells can also generate daughters with the same
lineage potential for limited periods of time, only HSCs can
self-renew for long enough to support the hematopoietic system
for a lifetime.
HSCs have a number of properties that make their transplanta-
tion easier than it is for other stem cells: even upon crude removal
from their normal cellular context—by simply sucking them out of
their niches and injecting them into the blood stream of a recip-
ient—they survive, retain their HSC potential, find their way
back to their normal niches, and resume their function in regener-
ating the hematopoietic system. This flexibility probably stems
from their normal migratory behavior, as they frequently leave
their niches into the blood stream and migrate to distant novel
lodging sites. Ease of manipulation has made HSCs the best-
understood type of adult mammalian stem cell, and for decades
the most successfully applied for clinical stem cell therapy.
The robust nature of HSC survival and function also allowed
the development of limiting dilution transplantation assays in
the mouse (Szilvassy et al., 1990; Till et al., 1964), which enable
precise retrospective quantification of HSC numbers in a given
cell population. The ultimate proof that individual cells harbor
full HSC potential came from successful long-term reconstitution
of the full blood system from a single transplanted cell (Osawa
et al., 1996). Serial transplantation of clonal HSC progeny further
demonstrated that HSC numbers can not only be maintained but
also expanded in vivo. HSCs therefore provide one of the best
examples for the amazing potential of adult stem cells, and the
great promise they hold for regenerative therapy.
Prospective HSC Isolation
Knowing that HSCs exist is not in itself useful for analyzing them
in more depth. They are very rare, and only one in thousands ofcells in the adult bone marrow is an HSC. Although a retrospec-
tive functional test through transplantation is the only way to
prove the HSC potential of a cell, the cell itself is long gone
when the test is completed and only its progeny are available
for further analysis. The identification of molecular markers that
allow prospective identification of HSCs was therefore an impor-
tant step. This approach has been the basis for HSC analyses for
decades, and continues to be refined through novel markers that
improve HSC enrichment. Combinations of antibodies against
surface markers and fluorescence activated cell sorting (Span-
grude et al., 1988) are usually used to purify specific populations,
which are then measured for HSC behavior, most commonly
by injecting cells into the circulation of recipient mice with a
depleted hematopoietic system to improve engraftment. HSC
potential is then determined by quantifying the long-term contri-
bution of the transplanted cells to the peripheral blood.
The definition of ‘‘HSC behavior,’’ however, is not an absolute
one. Reconstitution of the full hematopoietic system for life—
approximately 2 years in a mouse—would satisfy even the
most rigorous demands, but the current, somewhat arbitrary,
gold standard is less stringent: cells that keep the levels of
myeloid, T, and B cells at robustly detectable levels (typically
more than 1% of peripheral blood cells) for 16 weeks are defined
as HSCs. The reason for setting the threshold to 16 weeks is the
observation that there are progenitor populations within the mul-
tipotent hematopoietic compartment that can be prospectively
identified and whose progeny regularly exhaust before this time
point. To keep experimental time and effort reasonable, most
HSC transplantation experiments are therefore not analyzed
beyond this time point.
One of the earliest findings in prospective isolation was
that murine HSC activity resides in a population of adult bone
marrow cells that do not express any of several surface markers
found on different more mature blood cells (lineageneg, ‘‘L’’)
and expressing the markers c-kit (CD117, ’’K’’) and stem cell
antigen 1 (Sca-1, ‘‘S’’). However, only a few percent of the cells
in the still very heterogeneous ‘‘KSL’’ population have HSC
potential based on the assay described above. In a landmark
study, Nakauchi and colleagues found that 30%–40% of the
CD34lowKSL cells have HSC potential, when individually trans-
planted (Osawa et al., 1996). This level of enrichment made
molecular and behavioral analyses feasible. In subsequent
years, numerous alternative or improved HSC enrichmentCell Stem Cell 6, March 5, 2010 ª2010 Elsevier Inc. 203
Figure 1. Possible Explanations for Heterogeneous Clonal Output
from HSC Populations
Differences in clonal differentiation outcome from a HSC population could be
caused by (A) the presence of subpopulations (red and blue) with predeter-
mined future behavior. Alternatively (B), the different behavior of originally
equivalent cells (white) could later diverge via stochastic fate choices with
a certain probability or in response to different extrinsic signals. Changes in
the average HSC population behavior during aging could be explained by
(C) the changing proportion of HSC subtypes with constant properties, or by
(D) homogeneous changes of the properties of all older HSCs (black). Recent
findings discussed in this work support the existence of mechanisms illus-
trated in (A) and (C). HSC extrinsic signals are nevertheless essential for the
maintenance of the intrinsic self-renewal and lineage bias programs.
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used include CD201 (Balazs et al., 2006) and lack of CD49b
(Benveniste et al., 2010; Wagers and Weissman, 2006). In addi-
tion, HSC-specific functional properties such as low metabolic
activity, detected by low staining with the dye Rhodamin 123
(‘‘Rho,’’ [Li and Johnson, 1995]), or higher activity in pumping
out the fluorescent dye Hoechst 33342, leading to a population
of cells with low fluorescent intensity (‘‘side population’’ or
‘‘SP,’’ [Goodell et al., 1996]), can be used. The introduction of
SLAM markers for HSC enrichment, and in particular the expres-
sion of CD150 on HSCs (Kiel et al., 2005), was an important
improvement over previous approaches for several reasons.
Use of CD150 for HSC identification is less affected by mouse
age and genetic background than that of other markers. In addi-
tion, reducing the number of markers that need to be used simul-
taneously allows HSC identification in microscopic analyses
in situ. Moreover, CD150 was used in combination with most
laboratories’ favorite protocols for HSC enrichment, thereby
allowing comparison of results across studies. Finally, it has now
turned out to also enable the identification of previously unrecog-
nized cell subpopulations with distinct lineage and long-term
self-renewal potential within HSC populations enriched with
other approaches (Benveniste et al., 2010; Challen et al., 2010;
Kent et al., 2009; Kiel et al., 2005).
In principle, this type of prospective isolation and transplanta-
tion analysis strategy can also be used to study human HSCs.
However, development of such methods for human cells has
lagged behind the mouse system, and because it is a prerequisite
for the type of detailed molecular analyses that form the focus of
this review, the discussion below only covers mouse HSCs.
Heterogeneity of Currently Used HSC Populations
Despite all these options for HSC enrichment, our understanding
of normal and malignant HSC behavior and its molecular control
still is surprisingly limited. The main obstacles preventing precise
analysis are the low HSC numbers and the remaining heteroge-
neity of the cell populations yielded by existing purification
procedures. Only approximately a thousand HSCs can usually
be obtained from one mouse, and even within this small popula-
tion, individual cells differ widely in their behavioral and molec-
ular properties. The inherent problem of low HSC numbers
cannot be overcome, and improved molecular analysis will
require more sensitive high throughput methodologies allowing,
for example, comprehensive protein expression or chromatin
configuration analyses from a few or even single cells.
Heterogeneity within the enriched cell population might be
overcome, or at least reduced, by improved prospective HSC
isolation strategies. Functional heterogeneity within HSC popu-
lations can only be assessed with technically demanding and
lengthy clonal or single-cell analyses. When analyzed at the
single-cell level, the above enrichment strategies yield popula-
tions in which 30%–50% of the cells reliably read out as HSCs
on the basis of the current experimental standards. It is important
to bear in mind that the failure of the remaining cells to meet the
test criterion could be a result of the demanding experimental
approach used, and the proportion of functional HSCs might in
fact be higher. Nevertheless, the behavior of individual HSCs in
fulfilling even these requirements is still highly variable. The
numbers of mature cells that individual HSCs produce ranges204 Cell Stem Cell 6, March 5, 2010 ª2010 Elsevier Inc.from 1 to up to almost 100% of the recipient’s peripheral blood
cells (Benveniste et al., 2010; Dykstra et al., 2007; Muller-Sieburg
et al., 2002). In addition, the ratio of myeloid and lymphoid cells
generated can vary significantly between individual clones
(Challen et al., 2010; Dykstra et al., 2007; Muller-Sieburg et al.,
2004; Muller-Sieburg et al., 2002; Sieburg et al., 2006). There
are two basic models that could explain this type of heteroge-
neity within the HSC compartment. One is that it is still a mixture
of several cell types, each of which has different proliferation
potential and lineage production propensity (Figure 1A). How-
ever, it is also possible that the cells are in fact all equivalent
at the time of transplantation, and the heterogeneity in behavior
is a result of stochastic fate choices and/or differences in
extrinsic influences such as niche signals (Figure 1B). Recent
experiments have provided new insights into which of these
scenarios seems most likely to apply.
Lineage Biased HSC Subsets
Over the past few years, the underlying basis of HSC heteroge-
neity has been investigated in a number of time-consuming and
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output of individual HSCs over very long periods of time. In
a series of landmark papers, Muller-Sieburg and colleagues
analyzed the clonal progeny of HSCs after transplantation, con-
firming that the extent and kinetics of hematopoietic repopula-
tion strongly differ between individual HSCs. In addition, they
showed that, although contributing long-term to both lymphoid
and myeloid lineages, individual HSCs preferentially generated
myeloid or lymphoid progeny (Muller-Sieburg et al., 2002).
Importantly, they found that lineage preference and proliferation
differences were not stochastically regulated or dependent on
differences in environmental influence, but instead cell-intrinsi-
cally predetermined and stably inherited through serial trans-
plantation. They also found evidence that myeloid-biased
HSCs self-renew the longest and that their myeloid bias results
from reduced responsiveness to the lymphopoietic cytokine
IL-7 (Muller-Sieburg et al., 2004). Further analyses yielded a
limited set of additional HSC-specific behavioral patterns and
demonstrated that prospective HSC purification paradigms, in
this case with the lineagenegRholowSP phenotype, enriched
only for some of these HSC subsets (Sieburg et al., 2006). These
studies also yielded important information about how the prop-
erties of the HSC pool change during aging. Old hematopoietic
systems are characterized by reduced lymphopoiesis and
increased long-term self-renewal capacity of the HSC pool.
This observation lead to the assumption that individual HSCs
change their properties during aging (Figure 1D). However, these
recent studies now support an alternative explanation, in which
individual HSCs do not change their properties in older organ-
isms. Instead, it seems that the changing potential of the HSC
pool reflects a change in composition toward a greater propor-
tion of HSCs with myeloid bias and increased self-renewal
capacity (Figure 1C). Importantly, in this model the properties
of individual HSCs do not differ between young and old
lineage-biased HSCs.
This change in conclusion was confirmed and highlighted by
studies from the Eaves group, who used an extensive array of
transplantations of single HSCs that were prospectively enriched
with a protocol related to those described above (CD45mid
lineagenegRholowSP [Dykstra et al., 2007]). They confirmed that
repopulation kinetics, long-term self renewal potential, and
myeloid versus lymphoid bias are intrinsic HSC properties, stably
inherited to their HSC offspring. In addition, they showed that,
although being extremely stable in vivo, HSC subtype identity
was quickly lost in vitro, even under culture conditions that main-
tain overall HSC potential. These important findings demonstrate
that the HSC lineage bias is governed more by a stable intrinsic
epigenetic program than by extrinsic signals in vivo. Appropriate
environmental signals are nevertheless essential for the mainte-
nance both of HSC self-renewal and the lineage bias program.
Further analysis demonstrated that some HSC subtypes could
convert into others, although only in certain directions. This
finding, together with observation of HSC subtype conversion
in vivo, suggests a hierarchical relationship between those
subtypes, with myeloid-biased, longest-term self renewing HSCs
at its top. The Eaves group later described further improved
prospective isolation protocols, using combinations of CD150,
CD201, CD48, and CD45, for the enrichment of HSCs with
different self-renewal and lineage bias (Kent et al., 2009).In this issue of Cell Stem Cell, Goodell and colleagues provide
further insight about the molecular properties of HSC subtypes
(Challen et al., 2010). They demonstrate that detailed use of
the SP phenotype can separate myeloid (lower-SP) from
lymphoid (upper-SP) biased HSCs. CD150 again proved to be
useful for their enrichment approach, with its expression corre-
lating with myeloid bias and higher self-renewal potential. Inter-
estingly, prospective isolation and competitive transplantation
demonstrated that the behavioral bias of these HSC subtypes
is enhanced by the presence of other subtypes in the same
organism—suggesting a regulatory cross-talk between these
populations. Transcriptome analysis then led to the identification
of TGF-ß signaling as a potential contributor to differential regu-
lation of HSC subsets. As previously shown for IL-7 signaling
(Muller-Sieburg et al., 2004), Challen et al. found that the myeloid
and lymphoid subsets differ in their responsiveness for cytokines
of the TGF-ß family, with TGF-ß1 inducing and inhibiting prolifer-
ation of myeloid and lymphoid-biased HSCs, respectively. This
observation could also provide an explanation for the previously
described change in the composition of the HSC pool during
aging, which Challen et al. also observed. Sustained exposure
of the HSC pool to TGF-ß signals could lead to a proliferative
advantage and enrichment of myeloid relative to lymphoid
biased HSCs over time.
HSC Subsets with Different Self-Renewal Stability
In another recent Cell Stem Cell paper, the Iscove group
addressed HSC heterogeneity of a different kind: differences in
long-term HSC self-renewal capacity (Benveniste et al., 2010).
All of the findings discussed above about subtype heterogeneity
are based on the currently accepted operational gold standard
for functional definition of HSCs: the ability to produce lympho-
myeloid progeny of at least 1% of the recipient’s peripheral
blood at 16 weeks after transplantation. Whether this time frame
is sufficiently long, however, is matter of active discussion in the
field. Benveniste et al. therefore analyzed progeny of single
transplanted HSCs for much longer. First, they confirmed the
known but often ignored fact that the recent presence of HSCs
in the bone marrow should only be read out by looking at
short-lived progeny in the peripheral blood. Because mature
lymphoid cells can persist for a long time, the progeny cells
that came from a transplanted progenitor can still be present
even when the progenitor itself differentiated some time before
and no longer exists. They concluded that abundant short-lived
erythrocytes are the best mature cell population for monitoring
long-term HSC potential. They found that for some transplanted
HSCs, high-level erythroid contribution could be detected even
after 8 months, but others exhausted considerably earlier. Most,
although not all, of the clones they examined exhausted by
16 weeks after transplantation when using the erythroid read out.
Importantly, these cells would have qualified as ‘‘long-term’’
HSCs on the basis of the read outs used in many previous
studies in the field. This precise analysis now allowed the
description of a subset of HSCs with intermediate reconstitution
potential (ITRC HSCs) within the population previously defined
as ‘‘long-term HSCs.’’ These cells self-renew for longer than
previously described short-term HSCs or multipotent progeni-
tors (e.g., with CD34+KSL phenotype), but for less time than
true long-term reconstituting HSCs (LTRC HSCs), which yieldCell Stem Cell 6, March 5, 2010 ª2010 Elsevier Inc. 205
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after transplantation. Once again, prospective isolation of
these subpopulations demonstrated their existence. Within a
RholowKSL population, LTRC and ITRC HSCs can be separated
as CD49bneg and CD49bpos, respectively. CD49b and CD150
expression showed an inverse correlation, with the majority—
but not all—CD49bneg cells being CD150pos and of CD49bpos
cells being CD150neg. This capacity for prospective enrichment
also demonstrates that the behavior of these cells is an intrinsic
property that is already determined at the time of transplantation.
Benveniste et al. also found robust differences in the transcrip-
tome profiles of the two populations, laying the groundwork for
future analysis of the molecular mechanisms that control their
behavior.
Current Understanding and Open Questions
In conclusion, these studies have demonstrated that stable
subsets of HSCs with predetermined behavior exist within the
currently defined HSC compartment. How the different subsets
described by different groups—in particular the LTRC HSCs—
correlate with each other needs to be examined in future exper-
iments. On the basis of the current data, it seems likely that there
is an HSC subset characterized by having the longest-term self-
renewal capacity, myeloid biased progeny, and a CD49bneg
CD150pos CD48neg CD201pos lower-SP Rholow CD34low c-kitpos
Sca-1pos lineageneg phenotype. Which of the different subsets
will be defined as true HSCs, as opposed to multipotent progen-
itors, will probably prompt as much discussion in the field as
occurred previously about short-term HSCs.
Although it now seems clear that future fate choices are intrin-
sically predetermined in different HSC subtypes, it is important
not to discount the influence of environmental factors. Although
extrinsic signals do not override the intrinsic clonal lineage bias
in vivo, they are nevertheless necessary for the maintenance of
these epigenetic programs in HSCs, and for their self-renewal.
Cell-extrinsic signals also influence the fate decisions of myeloid
and lymphoid HSC progeny, both by supporting proliferation
and survival and by lineage instruction (Rieger et al., 2009).
However, these cell-extrinsic signals are interpreted differently
by progeny of different HSC subsets, probably as a result of
differential sensitivity to signaling pathway activation (Challen
et al., 2010; Muller-Sieburg et al., 2004). These important find-
ings will undoubtedly fuel further discussions about intrinsic
versus extrinsic control of hematopoietic cell fates choices
(Challen et al., 2010; Kent et al., 2009; Ogawa et al., 1983; Rieger
et al., 2009; Till et al., 1964).
Another important point to note is that although different HSC
subsets clearly exist in homeostatic situations in vivo, their
normal homeostatic behavior could differ from that exhibited
after transplantation. In addition, although individual HSCs can
contribute to all blood lineages continuously through serial
transplantations, it is currently not clear whether all HSCs
constantly contribute to hematopoiesis under homeostatic
conditions or whether different clones successively become
transient contributors (Lemischka et al., 1986). HSC subsets
other than the longest-term self-renewing HSCs could be impor-
tant contributors to homeostatic hematopoiesis and should
therefore not be ignored in future analyses. Approaches allowing
noninvasive labeling and long-term single-cell observation of206 Cell Stem Cell 6, March 5, 2010 ª2010 Elsevier Inc.homeostatic HSCs in vivo will ultimately be required to fully
understand hematopoiesis (Schroeder, 2008) and to confirm
the existence of stable lineage biased clonal outputs in physio-
logical hematopoiesis.
HSCs are the most comprehensively analyzed adult mamma-
lian stem cell type, and their analyses have been carried out for
longer and in a more quantitative and vigorous way than for
most stem cell systems. The fact that even after decades of
research additional levels of complexity continue to be found
within the HSC compartment may serve as an important warning
for research in other stem cell systems. Purity of cell populations
is a crucial prerequisite for their meaningful biological and
molecular analysis, as well as for their safe application for clinical
therapy. Vigorous testing of enrichment protocols by stringent
long-term functional tests, even though laborious, is essential.
A final important point is that even after enrichment with the
most up-to-date approaches, the resulting HSC populations
are not homogeneous. A large proportion still does not have
HSC potential, and how much behavioral and molecular hetero-
geneity exists within the newly-identified HSC subsets will need
to be addressed in future studies. Nevertheless, the increased
resolution with which we understand, and can prospectively
purify, mouse HSC subtypes will contribute to a better under-
standing of their fascinating ability to regenerate and repair
hematopoiesis. It will also guide research on human HSCs,
hopefully leading to the development of improved cell therapies,
and in particular efficient and safe ex vivo expansion of HSCs for
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